JS
Jeffrey J Scherman
Chief Accounting Officer

Jeffrey J Scherman insider trades: NeueHealth (NEUE) stock sales

Chief Accounting Officer, NeueHealth Last trade May 12, 2025 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2023
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 12, 2025NEUE↓ Sell$757
Mar 14, 2025NEUE↓ Sell$9K
Mar 12, 2025NEUE↓ Sell$6K
Mar 10, 2025NEUE↓ Sell$6K
Jan 6, 2025NEUE↓ Sell$10K
May 10, 2024NEUE↓ Sell$684
Mar 18, 2024NEUE↓ Sell$4K
Mar 15, 2024NEUE↓ Sell$1K
Mar 13, 2024NEUE↓ Sell$2K
Mar 8, 2024NEUE↓ Sell$3K
May 10, 2023BHG↓ Sell$2K
Mar 13, 2023BHG↓ Sell$18K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeffrey J Scherman's insider trades

Jeffrey J Scherman is Chief Accounting Officer at NeueHealth (NEUE). Since Mar 13, 2023, Jeffrey has reported no open-market purchases and 12 sales worth $62K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (10 filings), grants and awards (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEUE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.